Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Timm

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Inhalation Toxicology|June 19, 2004
Effects of concentrated fine ambient particles on rat plasma levels of asymmetric dimethylarginineJ Timothy Dvonch, Robert D Brook, Gerald J Keeler, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Sortilin inhibition treats multiple neurodegenerative lysosomal storage disordersHannah G Leppert, Joelle T Anderson, Kaylie J Timm, et al.
Infection|February 4, 2021
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patientsL Schmidt, B-E O Jensen, A Walker, et al.
Trials|January 6, 2026
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)M Olugbosi, M Beumont, L Lombard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Journal of Hepatology|November 9, 2010
Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infectionI Schulte, T Hitziger, S Giugliano, et al.
Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.
Alimentary Pharmacology & Therapeutics|March 15, 2018
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infectionJ von Felden, J Vermehren, P Ingiliz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2019
Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten DiseaseJacob T Cain, Shibi Likhite, Katherine A White, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 13, 2012
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infectionsV M Corman, M A Müller, U Costabel, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Inhalation Toxicology|June 19, 2004
Effects of concentrated fine ambient particles on rat plasma levels of asymmetric dimethylarginineJ Timothy Dvonch, Robert D Brook, Gerald J Keeler, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Sortilin inhibition treats multiple neurodegenerative lysosomal storage disordersHannah G Leppert, Joelle T Anderson, Kaylie J Timm, et al.
Infection|February 4, 2021
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patientsL Schmidt, B-E O Jensen, A Walker, et al.
Trials|January 6, 2026
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)M Olugbosi, M Beumont, L Lombard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Journal of Hepatology|November 9, 2010
Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infectionI Schulte, T Hitziger, S Giugliano, et al.
Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.
Alimentary Pharmacology & Therapeutics|March 15, 2018
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infectionJ von Felden, J Vermehren, P Ingiliz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2019
Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten DiseaseJacob T Cain, Shibi Likhite, Katherine A White, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 13, 2012
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infectionsV M Corman, M A Müller, U Costabel, et al.
Pageof 10